Inventor · disambiguated record
Gilles Ouvry
Also filed as: OUVRY GILLES
12 granted patents·7 pending applications·5 citations·filing 2008–2025
83Inventor score
Files withGALDERMA RES & DEV10ASTRAZENECA AB3JAZZ PHARMACEUTICALS IRELAND LTD3GOTO YASUHIRO1Galderma Holding SA1
Top patents by PatentIndex Score
19 records- 0184US10246440B2Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR γ (T))GALDERMA RES & DEV·Filed 2015·Granted Apr 2, 2019·2 cites·8 claims
- 0270US8017611B2Pyridine and pyrazine derivatives -083ASTRAZENECA AB·Filed 2008·Granted Sep 13, 2011·2 cites·4 claims
- 0369US9657008B2Chemical compoundsASTRAZENECA AB·Filed 2015·Granted May 23, 2017·1 cites·12 claims
- 0466US10752617B2Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))GALDERMA RES & DEV·Filed 2019·Granted Aug 25, 2020·0 cites·19 claims
- 0558US10618890B2Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))GALDERMA RES & DEV·Filed 2015·Granted Apr 14, 2020·0 cites·13 claims
- 0658US10550110B2Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t))GALDERMA RES & DEV·Filed 2015·Granted Feb 4, 2020·0 cites·20 claims
- 0758US2023279003A1Jak inhibitor compounds, method for synthesizing same and use thereofGalderma Holding SA·Filed 2023·Application pending·0 cites
- 0857US2019307758A1Trpa1 antagonists for use in the treatment of atopic dermatitisGALDERMA RES & DEV·Filed 2019·Application pending·0 cites
- 0956US9156831B2Chemical compoundsASTRAZENECA AB·Filed 2014·Granted Oct 13, 2015·0 cites·6 claims
- 1056US2025320227A1Macrocyclic orexin receptor agonists and uses thereofJAZZ PHARMACEUTICALS IRELAND LTD·Filed 2023·Application pending·0 cites
- 1155US2020390774A1Trpa1 antagonists for use in the treatment of atopic dermatitisGALDERMA RES & DEV·Filed 2020·Application pending·0 cites
- 1254US2024360081A1Sulfonamide orexin receptor agonists and uses thereofJAZZ PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 1353US2024254143A1Orexin receptor agonists and uses thereofJAZZ PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 1452US11518767B2MTOR inhibitor compoundsGALDERMA RES & DEV·Filed 2020·Granted Dec 6, 2022·0 cites·10 claims
- 1551US11731973B2Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitorsGALDERMA RES & DEV·Filed 2020·Granted Aug 22, 2023·0 cites·17 claims
- 1648US12491185B2Inhibitors of mPTPNRG THERAPEUTICS LTD·Filed 2025·Granted Dec 9, 2025·0 cites·30 claims
- 1745US2011183975A1Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activityGOTO YASUHIRO·Filed 2009·Application pending·0 cites
- 1837US10556883B2Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine and cosmeticsGALDERMA RES & DEV·Filed 2017·Granted Feb 11, 2020·0 cites·12 claims
- 1936US10457637B2Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T))GALDERMA RES & DEV·Filed 2015·Granted Oct 29, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Gilles Ouvry files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →